The benefit/risk ratio of low dose cyclosporin A in rheumatoid arthritis

J Rheumatol. 1996 Feb;23(2):404-5.
No abstract available

MeSH terms

  • Adult
  • Arthritis, Rheumatoid / drug therapy*
  • Cost-Benefit Analysis
  • Cyclosporine / administration & dosage*
  • Cyclosporine / therapeutic use
  • Humans
  • Middle Aged

Substances

  • Cyclosporine